BRENETAFUSP
UNII 5GK14JY4JE

Substance Identification & Data

This profile provides standardized clinical and technical data for Brenetafusp, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5GK14JY4JE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2736407-54-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5GK14JY4JE

CAS Registry Number

2736407-54-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRENETAFUSP

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199026

National Cancer Institute reference terminology for clinical and research data.

INN ID

12532

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-104

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brenetafusp. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRENETAFUSP

Common Names & Synonyms

BRENETAFUSP [INN]

BRENETAFUSP [USAN]

BRENETAFUSP [WHO-DD]

IMMUNOGLOBULIN, ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS SINGLE-CHAIN FV FRAGMENT VL-((GGGGS)4GGGS)-VH) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH T-CELL RECEPTOR .BETA. CHAIN (171-CYSTEINE,189-ALANINE,203-ASPARATIC ACID) ANTI-(HUMAN HLA-A2 ANTIGEN COMPLEX WITH PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA PROTEIN PEPTIDE) (HUMAN N-TERMINAL FRAGMENT), DISULFIDE WITH T CELL RECEPTOR .ALPHA. CHAIN (163-CYSTEINE) ANTI-(HUMAN HLA-A2 ANTIGEN COMPLEX WITH PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA PROTEIN PEPTIDE) (HUMAN N-TERMINAL FRAGMENT)

Technical Codes

IMC F106C

IMC-F106C

External Clinical & Regulatory Resources

Previous UNII5GJ3MRW91Q

Next UNII5GK8CV7MAN